In re HIV Antitrust Litigation

UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA San Francisco Division PETER STALEY, et al., Case No. 19-cv-02573-EMC (LB)

Plaintiffs,

DISCOVERY ORDER

v. Re: ECF No. 1243 GILEAD SCIENCES, INC., et al., Defendants. 16 INTRODUCTION The parties dispute whether the individual health-plan plaintiffs may provide information marked confidential under the Supplemental Protective Order (ECF No. 484) to Stephen R. Auten so that he may present reply expert testimony.1 Defendant Teva Pharmaceuticals USA, Inc. seeks to bar the individual health-plan plaintiffs from (1) providing Teva’s confidential information to Mr. Auten or (2) using him as an expert, based on his work for Teva in a different matter (i.e., the Actavis Tax Matter).2 The issue is whether Mr. Auten’s past work for Teva presents a conflict that 24 25 1 Joint Disc. Ltr. – ECF No. 1243 at 1–2 (The individual health-plan plaintiffs include Humana Inc., Blue Cross and Blue Shield of Florida, Inc.…